摘要
目的为新型冠状病毒(简称新冠病毒)感染患者的居家合理用药提供参考。方法查阅国家卫生健康委员会官网公布的《新冠病毒感染者居家治疗指南》(以下简称《指南》),根据患者症状的不同,对推荐用药方案中涉及药物按西药、中成药进行分类统计,结合各药品的药品说明书,并根据不同人群用药特点,梳理其用药安全风险点。结果《指南》推荐的居家治疗药物包括西药15种(对应症状8种),中成药8种(对应症状4种)。共梳理出数十条用药安全风险点。结论根据《指南》梳理出的用药安全风险点,可为新冠病毒感染人群的居家合理用药提供参考。
Objective To provide a reference for home-based rational drug use of patients with corona virus disease 2019(COVID-19).Methods Refering to the Guidelines for Home-Based Treatment of Patients with COVID-19(hereinafter referred to as the Guidelines)issued by the official website of the National Health Commission of the People's Republic of China,the drugs involved in the recommended medication regimen were classified into the western medicines and Chinese patent medicines according to different symptoms of patients.Refering to the drug instructions,the medication safety risk points were sorted out based on the medication characteristics of different populations.Results There were 15 kinds of western medicines(eight kinds of corresponding symptoms)and eight kinds of Chinese patent medicines(four kinds of corresponding symptoms)recommended in the Guidelines for home-based treatment.Dozens of medication safety risk points were sorted out.Conclusion The medication safety risk points based on the Guidelines can provide a reference for the home-based rational drug use of patients with COVID-19.
作者
刘荣
任常谕
周后凤
赵玉林
鲁征
LIU Rong;REN Changyu;ZHOU Houfeng;ZHAO Yulin;LU Zheng(The Fifth People's Hospital of Chengdu,Chengdu,Sichuan,China 611130)
出处
《中国药业》
CAS
2023年第16期123-126,共4页
China Pharmaceuticals
基金
四川省卫生健康委员会医学科技项目[21PJ149]。
关键词
新型冠状病毒感染
《新冠病毒感染者居家治疗指南》
居家用药
安全风险点
corona virus disease 2019
Guidelines for Home-Based Treatment of Patients with COVID-19
home-based drug use
safety risk points
